Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Maria I. Harrell | Researchclopedia

Back to researchers

Maria I. Harrell

LabCorp (United States)

135

Works

10,646

Citations

34

h-index

43

i10-index

Research Topics

PARP inhibition in cancer therapy Ovarian cancer diagnosis and treatment BRCA gene mutations in cancer

Affiliations

Center for Infectious Disease Research2000–2012

Seattle Children's Hospital2011–2013

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa2007–2011

Medical University of South Carolina2011–2011

Bristol-Myers Squibb (Germany)2017–2017

Top Works

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial

Elizabeth M. Swisher,Kevin Lin,et al.

20161,191 citations

Cancer Genomics and Diagnostics

DNA Repair Mechanisms

Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas

Kathryn P. Pennington,Tom Walsh,et al.

20131,039 citations

Inhibition of Respiration by Nitric Oxide Induces a<i>Mycobacterium tuberculosis</i>Dormancy Program

Martin I. Voskuil,Dirk Schnappinger,et al.

2003971 citations

Inherited Mutations in Women With Ovarian Carcinoma

Barbara M. Norquist,Maria I. Harrell,et al.

2015752 citations

Regulation of the<i>Mycobacterium tuberculosis</i>hypoxic response gene encoding α-crystallin

David R. Sherman,Martin I. Voskuil,et al.

2001740 citations

Rv3133c/<i>dosR</i> is a transcription factor that mediates the hypoxic response of <i>Mycobacterium tuberculosis</i>

H D Park,Kristi M. Guinn,et al.

2003726 citations

The Enduring Hypoxic Response of Mycobacterium tuberculosis

Tige R. Rustad,Maria I. Harrell,et al.

2008501 citations

Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance

Stephen J. Pettitt,Dragomir B. Krastev,et al.

2018438 citations

<i>BRCA</i> Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

Kevin Lin,Maria I. Harrell,et al.

2018415 citations